Familial Erythrocytosis 4
3 drugs in active Familial Erythrocytosis 4 trials · Updated 18 Nov 2026
Furthest along
3 in Phase 1
Next Phase 3 result
None yet
Drugs
3
In active trials, any stage
Trials
1 active
No sub-diseases
Drugs3
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1 | Mar 2029Phase 1 trial completes | |||
| Next date | Mar 2029 · Phase 1 trial completes | ||||
| Also tested for | Clear Cell Renal Cell Carcinoma, Solid Tumors | ||||
| Open drug page | |||||
PD-1/VEGF bispecific antibody |
Akeso +1 · Public 9926.HK · SMMT |
Phase 1 | Mar 2029Phase 1 trial completes | ||
| How it works | A cancer drug that hits two targets at once | ||||
| Next date | Mar 2029 · Phase 1 trial completes | ||||
| Also tested for | Clear Cell Renal Cell Carcinoma, Solid Tumors | ||||
| Open drug page | |||||
Monoclonal antibody |
Phase 1 | Mar 2029Phase 1 trial completes | |||
| How it works | An antibody | ||||
| Next date | Mar 2029 · Phase 1 trial completes | ||||
| Also tested for | Clear Cell Renal Cell Carcinoma, Solid Tumors | ||||
| Open drug page | |||||
About
- Summary
- 3 drugs are in active Familial Erythrocytosis 4 trials. Updated 18 Nov 2026.
- Registry term
- Erythrocytosis, Familial, 4
- Counts
- Active trials the registry tags with the term or a term under it, at any stage. A search also reads trial titles and drug names, so its counts differ.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026